Last edition
News about Global Pharma
US FDA Issues 8 Observations for Natco Pharma Unit in Hyderabad
The company is confident of addressing all the observations within the stipulated time and working with US FDA to close them at the earliest, it said in a filing.
Global Pharma | 23/10/2023 | By Manvi | 1187
Linde Starts Up New Air Separation Unit in Hyderabad
This plant will be producing in total 250 tonnes per day of gases including liquid medical oxygen, nitrogen and argon, catering to the requirements of healthcare, pharma and other industrial sectors of the region.
Global Pharma | 23/10/2023 | By Manvi | 318
Shilpa Medicare Ltd, Unit IV, Jadcherla, Telangana Clears TGA, Australia GMP Inspection
The facility is involved in manufacturing, packaging, labelling, testing and release of finished dosage forms (sterile injections and non-sterile oral solids) for the treatment of various forms of cancer and adjuvant therapy.
Global Pharma | 23/10/2023 | By Manvi | 1611
The FDA has determined the inspection classification as 'OAI' (Official Action Indicated). The OAI status may cause delay and/or withholding of pending product approvals or supplements from the facility.
Global Pharma | 23/10/2023 | By Manvi | 733
Dermatological diseases affect more than 900 million people worldwide. Significant advancements in the treatment of various skin conditions and disorders have been made.
Global Pharma | 23/10/2023 | By Manvi | 469
C2 PHARMA Expands API Portfolio with Global Regulatory Access Ahead of CPhI Barcelona
C2 PHARMA is expanding its global access to its portfolio of active pharmaceutical ingredients (APIs) with new regulatory submissions and approvals.
Global Pharma | 18/10/2023 | By Manvi | 949
Linde Starts Up New Air Separation Unit in Hyderabad
This plant will be producing in total 250 tonnes per day of gases including liquid medical oxygen, nitrogen and argon, catering to the requirements of healthcare, pharma and other industrial sectors of the region.
Global Pharma | 18/10/2023 | By Manvi | 444
Zydus Appoints Punit Patel as President and CEO to Lead its Business Operations in North America
He will be responsible for the business operations of all Zydus entities in North America which include generics, injectables and specialty business, rare and orphan disease portfolio and also future forays into novel therapeutics. He will be based out of the group's office in Pennington, New Jersey, US.
Global Pharma | 18/10/2023 | By Manvi | 830
Bajaj Healthcare Completes Construction of Alkaloid Extraction Plant at Gujarat Unit
The company has Constructed Alkaloid Extraction plant at its Vadodara Unit situated at Gujarat. Plant has a capacity for extraction of 2500 Mt of poppy Straw & 300 Mt Poppy Gum per year.
Global Pharma | 16/10/2023 | By Manvi | 994
Granules India Signs MoU with NIPER to Establish CCE-ISPD
The centre will focus on crucial areas such as exploring plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods in producing directly compressible crystals, promotion of solvent-free pharmaceutical processes, and the development of resource-efficient and energy-efficient pharmaceutical products.
Global Pharma | 16/10/2023 | By Manvi | 633
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy